Man, KKC; Chan, EW; Ip, P; Coghill, D; Simonoff, E; Chan, PKL; Lau, WCY; ... Wong, ICK; + view all Man, KKC; Chan, EW; Ip, P; Coghill, D; Simonoff, E; Chan, PKL; Lau, WCY; Schuemie, MJ; Sturkenboom, MCJM; Wong, ICK; - view fewer (2017) Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study. BMJ - British Medical Journal , 357 , Article j2350. 10.1136/bmj.j2350.

Preview

Text BMJ 2017 ADHD and Prenatal Antidepressant Exposure.pdf - Published Version Download (557kB) | Preview

Abstract

OBJECTIVE: To assess the potential association between prenatal use of antidepressants and the risk of attention-deficit/hyperactivity disorder (ADHD) in offspring. DESIGN: Population based cohort study. SETTING: Data from the Hong Kong population based electronic medical records on the Clinical Data Analysis and Reporting System. PARTICIPANTS: 190 618 children born in Hong Kong public hospitals between January 2001 and December 2009 and followed-up to December 2015. MAIN OUTCOME MEASURE: Hazard ratio of maternal antidepressant use during pregnancy and ADHD in children aged 6 to 14 years, with an average follow-up time of 9.3 years (range 7.4-11.0 years). RESULTS: Among 190 618 children, 1252 had a mother who used prenatal antidepressants. 5659 children (3.0%) were given a diagnosis of ADHD or received treatment for ADHD. The crude hazard ratio of maternal antidepressant use during pregnancy was 2.26 (P<0.01) compared with non-use. After adjustment for potential confounding factors, including maternal psychiatric disorders and use of other psychiatric drugs, the adjusted hazard ratio was reduced to 1.39 (95% confidence interval 1.07 to 1.82, P=0.01). Likewise, similar results were observed when comparing children of mothers who had used antidepressants before pregnancy with those who were never users (1.76, 1.36 to 2.30, P<0.01). The risk of ADHD in the children of mothers with psychiatric disorders was higher compared with the children of mothers without psychiatric disorders even if the mothers had never used antidepressants (1.84, 1.54 to 2.18, P<0.01). All sensitivity analyses yielded similar results. Sibling matched analysis identified no significant difference in risk of ADHD in siblings exposed to antidepressants during gestation and those not exposed during gestation (0.54, 0.17 to 1.74, P=0.30). CONCLUSIONS: The findings suggest that the association between prenatal use of antidepressants and risk of ADHD in offspring can be partially explained by confounding by indication of antidepressants. If there is a causal association, the size of the effect is probably smaller than that reported previously.

Download activity - last month

Export as XMLCSVJSON

Download activity - last 12 months

Export as JSONXMLCSV

Downloads by country - last 12 months

Export as JSONCSVXML

Archive Staff Only

View Item